Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Pila Pharma AB
Industry Sector: N/A
CEO: N/A
Number Of Employees: N/A
Enterprise Value: N/A
PE Ratio: N/A
Exchange/Ticker 1: CSE:PILA
Exchange/Ticker 2: N/A
Latest Market Cap: N/A
BioCentury | Oct 5, 2021
Product Development
Lengthy TRPV1 pipeline now backed by Nobel prize
The now Nobel Prize-winning discovery of TRPV1 has led to a well-stocked therapeutic pipeline
Items per page:
1 - 1 of 1